Clinical trial
A Feasibility Trial of Self-Acupuncture for Chemotherapy Cancer Patients (SACC Trial)
NCT05929690 is registered in ClinicalTrials.gov with University College London Hospitals as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Feasibility Trial of Self-Acupuncture for Chemotherapy Cancer Patients (SACC Trial)
- Lead sponsor
- University College London Hospitals
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- November 16, 2023
- Completion date
- December 31, 2024
- Enrollment
- 80 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cancer